Journal article
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Abstract
BACKGROUND: Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19.
METHODS: In this open-label, adaptive, multiplatform, controlled trial, we randomly assigned patients who were hospitalized with Covid-19 and who were not …
Authors
Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR
Journal
The New England Journal of Medicine, Vol. 385, No. 9, pp. 790–802
Publisher
Massachusetts Medical Society
Publication Date
August 26, 2021
DOI
10.1056/nejmoa2105911
ISSN
0028-4793